RP- HPLC Method Development And Validation For Estimation Of Dapagliflozin In Tablet Formulation

  • L.B. Borse
  • M.S. Wagh
  • S.L. Borse
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

A novel, sensitive, suitable and robust strong-cation-exchange RP-HPLC technique was designed and evaluated towards the purpose of identifying dapagliflozin in tablet formulation. The separation was performed with HPLC system containing UV- detector with Openlab EZchrome software and kromasil C18, and methanol and water (75:25 % v/v) as mobile phase flowing at 1.0 ml/min. using UV detector, the detection was performed at 223 nm. Dapagliflozin was eluted with retention time of 5.27 min. The results of analysis have been evaluated with respect to stability, specificity, linearity, accuracy, precision (repeatability and intermediate precision) and robustness. A simple, specific, rapid and reproducible technique has been designed in order to analyse dapagliflozin in tablet formulation.

Cite

CITATION STYLE

APA

L.B. Borse, M.S. Wagh, S.L. Borse, S.P. Ahire, I.S. Vaishnav, V.D. Naphade, & V. S. Gulecha. (2022). RP- HPLC Method Development And Validation For Estimation Of Dapagliflozin In Tablet Formulation. Journal of Pharmaceutical Negative Results, 364–372. https://doi.org/10.47750/pnr.2022.13.s05.53

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free